中华胸心血管外科杂志
中華胸心血管外科雜誌
중화흉심혈관외과잡지
Chinese Journal of Thoracic and Cardiovascular Surgery
2015年
5期
278-281
,共4页
徐荣建%苗齐%刘兴荣%张超纪%马国涛%曹丽华%刘剑州%黄卓%李晓凤
徐榮建%苗齊%劉興榮%張超紀%馬國濤%曹麗華%劉劍州%黃卓%李曉鳳
서영건%묘제%류흥영%장초기%마국도%조려화%류검주%황탁%리효봉
心内膜炎%病原菌%药敏分析%心脏外科手术
心內膜炎%病原菌%藥敏分析%心髒外科手術
심내막염%병원균%약민분석%심장외과수술
Endocarditis%Pathogen%Drug sensitivity%Cardiac surgical procedures
目的 回顾性分析活动期感染性心内膜炎患者血培养及药敏结果,为临床合理选择抗菌药提供依据,探讨早期手术治疗活动期感染性心内膜炎的疗效.方法 2010年5月至2014年7月北京协和医院共收治62例活动期感染性心内膜炎患者,其中男46例,女16例,年龄18 ~81岁,平均(44.6±12.7)岁.所有患者均行体外循环下早期外科治疗,回顾性分析并比较其易感因素、临床表现、超声心动图结果、血培养结果、药敏结果及预后.术后长期随访,终点为死亡或IE复发,随访内容包括评估心功能、有无IE复发等.结果 共分离病原菌65株,主要为链球菌42株、粪肠球菌7株和金葡菌4株.药敏结果显示链球菌对阿奇霉素、克林霉素、红霉素耐药率分别为50.0%、64.3%、66.7%;粪肠球菌对四环素、利福平耐药率均为71.4%;金葡菌对复方新诺明、红霉素耐药率均为50.0%,对青霉素G100%耐药;3种病原菌对利奈唑胺、万古霉素敏感率均>80.0%.围手术期死亡2例,死因分别为感染性休克和低心排血量综合征.术后随访1~49个月,平均(16.9±10.9)个月,随访57例,失访3例.心功能NY-HA分级Ⅰ级42例,Ⅱ级15例,随访期间均无感染性心内膜炎复发.结论 感染性心内膜炎病原菌以革兰氏阳性菌为主,临床医师需根据病原菌耐药情况合理选择抗菌药,早期手术治疗效果满意.
目的 迴顧性分析活動期感染性心內膜炎患者血培養及藥敏結果,為臨床閤理選擇抗菌藥提供依據,探討早期手術治療活動期感染性心內膜炎的療效.方法 2010年5月至2014年7月北京協和醫院共收治62例活動期感染性心內膜炎患者,其中男46例,女16例,年齡18 ~81歲,平均(44.6±12.7)歲.所有患者均行體外循環下早期外科治療,迴顧性分析併比較其易感因素、臨床錶現、超聲心動圖結果、血培養結果、藥敏結果及預後.術後長期隨訪,終點為死亡或IE複髮,隨訪內容包括評估心功能、有無IE複髮等.結果 共分離病原菌65株,主要為鏈毬菌42株、糞腸毬菌7株和金葡菌4株.藥敏結果顯示鏈毬菌對阿奇黴素、剋林黴素、紅黴素耐藥率分彆為50.0%、64.3%、66.7%;糞腸毬菌對四環素、利福平耐藥率均為71.4%;金葡菌對複方新諾明、紅黴素耐藥率均為50.0%,對青黴素G100%耐藥;3種病原菌對利奈唑胺、萬古黴素敏感率均>80.0%.圍手術期死亡2例,死因分彆為感染性休剋和低心排血量綜閤徵.術後隨訪1~49箇月,平均(16.9±10.9)箇月,隨訪57例,失訪3例.心功能NY-HA分級Ⅰ級42例,Ⅱ級15例,隨訪期間均無感染性心內膜炎複髮.結論 感染性心內膜炎病原菌以革蘭氏暘性菌為主,臨床醫師需根據病原菌耐藥情況閤理選擇抗菌藥,早期手術治療效果滿意.
목적 회고성분석활동기감염성심내막염환자혈배양급약민결과,위림상합리선택항균약제공의거,탐토조기수술치료활동기감염성심내막염적료효.방법 2010년5월지2014년7월북경협화의원공수치62례활동기감염성심내막염환자,기중남46례,녀16례,년령18 ~81세,평균(44.6±12.7)세.소유환자균행체외순배하조기외과치료,회고성분석병비교기역감인소、림상표현、초성심동도결과、혈배양결과、약민결과급예후.술후장기수방,종점위사망혹IE복발,수방내용포괄평고심공능、유무IE복발등.결과 공분리병원균65주,주요위련구균42주、분장구균7주화금포균4주.약민결과현시련구균대아기매소、극림매소、홍매소내약솔분별위50.0%、64.3%、66.7%;분장구균대사배소、리복평내약솔균위71.4%;금포균대복방신낙명、홍매소내약솔균위50.0%,대청매소G100%내약;3충병원균대리내서알、만고매소민감솔균>80.0%.위수술기사망2례,사인분별위감염성휴극화저심배혈량종합정.술후수방1~49개월,평균(16.9±10.9)개월,수방57례,실방3례.심공능NY-HA분급Ⅰ급42례,Ⅱ급15례,수방기간균무감염성심내막염복발.결론 감염성심내막염병원균이혁란씨양성균위주,림상의사수근거병원균내약정황합리선택항균약,조기수술치료효과만의.
Objective To analyze the distribution and drug sensitivity of pathogens in blood culture in active infective endocarditis so as to provide the basis for rational use of antibiotics in clinic.To evaluate the impact of early surgical treatment for active infective endocarditis.Methods Blood culture results and clinical data of 62 consecutive patients with active infective endocarditis in Peking Union Medical College Hospital from May 2010 to July 2014 were retrospectively reviewed.All patients underwent early surgical treatment in conventional hypothermic cardiopulmonary bypass.The long-term follow-up after cardiac surgery was conducted.Results 65 trains of pathogenic bacteria were isolated.Streptococcus(n =42),Enterococcus faecalis(n =7) and Staphylococcus aureus(n =4) were the main three common pathogens.Resistance rates of Streptococcus to azithromycin,clindamycin and erythromycin were 50.0%,64.3% and 66.7% respectively.Resistance rates of Enterococcus faecalis to both of tetracycline and rifampicin were 50.0%.Resistance rates of Staphylococcus aureus to both of SMZ-TMP and erythromycin were 50.0%,which to penicillin G were 100%.Sensitive rates of three bacteria to both of linezolid and vancomycin were more than 80.0%.Two cases died from infectious shock and low cardiac output syndrome during the perioperative period.Other 60 patients recovered smoothly.The number of patients recovered with Ⅰ and Ⅱ grade heart function(NYHA) were 42 and 15 respectively during the follow-up period.There was no relapse of endocarditis occurred during the period of follow-up.Conclusion The pathogen of patients with infective endocarditis is mainly Gram-positive bacteria.Clinicians should choose the rational antibacterial drug according to the situation of resistance of pathogenic bacteria.Early surgical treatment can achieve satisfactory effectiveness for active infective endocarditis.